BI-8626

N/A

Report date: 2023/03/21 11:14:28
NME

Base Information

Drug NameBI-8626
Drug Alias NameBI-8626
ClassificationSmall molecules
Mechanisms of ActionE3 ubiquitin-protein ligase HUWE1 inhibitors
TargetsE3 ubiquitin-protein ligase HUWE1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A